HOME ABOUT US PRINT PUBLICATIONS SUBSCRIPTIONS CONTACT US TELL FRIEND RSS

Welcome to FDAweb Pay Per View Search our 65,021 - story database FREE   Free Items  Warning Letters  FDA Notices  FDA Calendar    FDA Whistleblowers            1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Next >>   Mammography Quality Assurance Advisory Panel Renewal [71 Words] [ Price : $8.95] Federal Register notice: FDA renews the National Mammography Quality Assurance Advisory Committee for an additional two years. 08/13/2019     Comments Sought on Device Q-Submission Program [91 Words] [ Price : $8.95] Federal Register notice: FDA seeks comments on an information collection extension for its “Q-Submission Program for Medical Devices” (OMB Control Number 0910-0756). 08/13/2019     Revised Guide Gastroparesis Drug Development [102 Words] [ Price : $8.95] FDA revises a 2015 draft guidance on “Gastroparesis: Clinical Evaluation of Drugs for Treatment.” 08/13/2019     Info Collection Extension for Device Accessories [84 Words] [ Price : $8.95] Federal Register notice: FDA sends to OMB an information collection extension for its guidance on medical device accessories. 08/13/2019     Drug Recalls Down, Units Up [2918 Words] [ Price : $8.95] The Stericycle Recall Index says drug recalls are dropping but the number of recalled units is increasing, while medical device recalls and units are dropping. 08/13/2019     FDA Inactivating Some Drug Listing Records [2825 Words] [ Price : $8.95] FDA says it will start inactivating drug listing records that are improperly listed according to agency requirements. 08/13/2019     QS Violations in Talon Inspection [2953 Words] [ Price : $8.95] FDA warns Talon about Quality System and other violations in its production of Class 1 and 2 medical devices. 08/13/2019     CGMP Violation in Emcure Inspection [2859 Words] [ Price : $8.95] FDA warns India’s Emcure Pharmaceuticals about a CGMP issue in its production of finished pharmaceuticals. 08/13/2019     No Higher Prostate Cancer Risk with Entacapone [2695 Words] [ Price : $8.95] FDA says further study has indicated no increased risk of prostate cancer for users of Comtan or Stalevo to treat Parkinson’s disease. 08/13/2019     FDA Resists Criticism of Postmarketing Requirements: Study [2777 Words] [ Price : $8.95] Dalhousie University professor Matthew Herder says FDA appears resigned to and resistant to criticism of its increasing regulatory reliance on postmarketing requirements. 08/13/2019       1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  Next >>

FERDIC INCORPORATED - P.O. Box 28, Camp Hill, PA 17001 | Phone: (717)731-1426 fax:(717)731-1427 Email: info@fdaweb.com